Reasons to exercise caution when considering a screening program for type 2 diabetes mellitus

Mayo Clinic Proceedings

Volumn 84, Issue 1, 2009, Pages 34-36

  Lawler, Frank H ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; METFORMIN; SULFONYLUREA;

CARDIOVASCULAR RISK; EVIDENCE BASED MEDICINE; EXERCISE; GLUCOSE TOLERANCE; HEART INFARCTION; HUMAN; MEDICAL PRACTICE; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; SCREENING TEST; HEALTH; MASS SCREENING; ORGANIZATION AND MANAGEMENT; PRACTICE GUIDELINE;

DIABETES MELLITUS, TYPE 2; HUMANS; MASS SCREENING; MORBIDITY; PRACTICE GUIDELINES AS TOPIC; WORLD HEALTH;

EID: 58749090755     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/84.1.34     Document Type: Note

References (13)

1. US Preventive Services Task Force. Screening for type 2 diabetes mellitus in adults: U.S. Preventive Services Task Force recommendation statement [published correction appears in Ann Intern Med. 2008;149(2):147]. Ann Intern Med. 2008;148(11):846-854.
2. Sheehy AM, Coursin DB, Gabbay RA. Back to Wilson and Jungner: 10 good reasons to screen for type 2 diabetes mellitus. Mayo Clin Proc. 2009;84(1):38-42.
3. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-Year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008 Oct 9;359(15):1577-1589. Epub 2008 Sep 10.
4. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) [published correction appears in Lancet. 1998;352(9139):1558]. Lancet. 1998;352(9131):854-865.
5. ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008 Jun 12;358(24):2560-2572. Epub 2008 Jun 6.
6. Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008 Jun 12;358(24):2545-2559. Epub 2008 Jun 6.
7. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977-986.
8. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 [published correction appears in BMJ. 1999;318(7175):29]. BMJ. 1998;317(7160):703-713.
9. Wilson JMG, Jungner G. Principles and Practice of Screening for Disease. World Health Organization Public Health Papers, No. 34; 1968. http://whqlibdoc.who.int/php/WHO-PHP-34.pdf. Accessed November 28, 2008.
10. Screening criteria: the Wilson-Jungner criteria for appraising the validity of a screening programme. www.gp-training.net/training/tutorials/ management/audit/screen.htm. Accessed November 28, 2008.
11. Barratt A, Irwig L, Glasziou P, et al; Evidence-Based Medicine Working Group. Users' guides to the medical literature, XVII: how to use guidelines and recommendations about screening. JAMA.1999;281(21):2029-2034.
12. Weinstein MC, Fineberg HV. Clinical Decision Analysis. Philadelphia, PA: WB Saunders; 1980.
13. Gilks WR, Richardson S, Spiegelhalter DJ. Markov Chain Monte Carlo in Practice. London, England: Chapman & Hall; 1996.